Evaluation of the results of preclinical studies of new antituberculosis compositions based on oxidized dextran and isonicotinic acid hydrazide
No. 3 (2016), Phthisiology
No. 3 (2016)

Evaluation of the results of preclinical studies of new antituberculosis compositions based on oxidized dextran and isonicotinic acid hydrazide

Phthisiology
Published 2016-10-18 — Updated on 2020-04-14
  • A. Zharkov
  • V. Shkurupiy
  • E. Liadov
  • B. Pevchenko
  • A. Frolov
  • D. Glazev
A. Zharkov
V. Shkurupiy
E. Liadov
B. Pevchenko
A. Frolov
D. Glazev
PDF (Русский)

Keywords

ДЕКСТРАЗИД, ОКИСЛЕННЫЙ ДЕКСТРАН, OXIDIZED DEXTRAN, ИЗОНИАЗИД, ISONIAZID, ГИДРАЗИД ИЗОНИКОТИНОВОЙ КИСЛОТЫ, HYDRAZIDE OF ISONICOTINIC ACID, ХРОНИЧЕСКАЯ ТОКСИЧНОСТЬ, CHRONIC TOXICITY, DEKSTRAZID

Abstract

The article presents the results of clinical trials conducted in the framework of the state contract № 14.N08.12.0007, antituberculosis agents, based on the oxidized dextran and isonicotinic acid hydrazide. Chronic developed an- tituberculosis compositions drugs has been established as a result of the work done.

PDF (Русский)